Kliniczne aspekty chorób układu hormonalnego: część 1 i 2 | Clinical Aspects of Endocrine Diseases: part 1 and 2

Tooltip .tooltip { position: relative; cursor: pointer; text-decoration: none; border-bottom: 1px dashed rgba(0, 0, 0, 0.6); } .tooltip::before { content: attr(data-tooltip); position: absolute; top: -40px; /* Trochę niżej nad słowem */ left: 50%; /* Wyśrodkowanie */ transform: translateX(-50%); background-color: rgba(255, 255, 255, 0.9); color: #333; padding: 6px 12px; border-radius: 8px; white-space: nowrap; opacity: 0; visibility: hidden; transition: opacity 0.3s ease, visibility 0.3s ease; font-family: ‘Arial’, sans-serif; font-size: 14px; box-shadow: 0px 4px 8px rgba(0, 0, 0, 0.1); z-index: 10; } .tooltip:hover::before { opacity: 1; visibility: visible; } document.addEventListener(‘DOMContentLoaded’, function () { const wordsToTooltip = { “Diabetes Mellitus”: “Cukrzyca”, “chronic metabolic disorder”: “Przewlekłe zaburzenie metaboliczne”, “hyperglycemia”: “Hiperglikemia”, “defects in insulin secretion”: “Wady w wydzielaniu insuliny”, “insulin action”: “Działanie insuliny”, “insulin resistance”: “Insulinooporność”, “endocrine disorders”: “Zaburzenia endokrynologiczne”, “organ complications”: “Powikłania narządowe”, “kidneys”: “Nerki”, “nerves”: “Nerwy”, “cardiovascular system”: “Układ sercowo-naczyniowy”, “Type 1 Diabetes (T1D)”: “Cukrzyca typu 1”, “autoimmune condition”: “Choroba autoimmunologiczna”, “beta cells”: “Komórki beta”, “insulin-producing”: “Produkujące insulinę”, “lifelong insulin therapy”: “Dożywotnia terapia insulinowa”, “genetic predisposition”: “Predyspozycje genetyczne”, “environmental factors”: “Czynniki środowiskowe”, “viral infections”: “Infekcje wirusowe”, “absolute insulin deficiency”: “Całkowity niedobór insuliny”, “Type 2 Diabetes (T2D)”: “Cukrzyca typu 2”, “adults”: “Dorośli”, “relative insulin deficiency”: “Względny niedobór insuliny”, “sedentary lifestyle”: “Siedzący tryb życia”, “obesity”: “Otyłość”, “poor dietary habits”: “Złe nawyki żywieniowe”, “central obesity”: “Otyłość centralna”, “Gestational Diabetes Mellitus (GDM)”: “Cukrzyca ciążowa”, “pregnancy”: “Ciąża”, “elevated blood glucose levels”: “Podwyższony poziom glukozy we krwi”, “risk of T2D”: “Ryzyko rozwoju cukrzycy typu 2”, “Other Specific Types”: “Inne specyficzne typy”, “monogenic diabetes”: “Cukrzyca monogenowa”, “secondary diabetes”: “Cukrzyca wtórna”, “Cushing’s syndrome”: “Zespół Cushinga”, “pancreatitis”: “Zapalenie trzustki”, “Risk Factors”: “Czynniki ryzyka”, “family history”: “Historia rodzinna”, “genetic markers”: “Markery genetyczne”, “ethnicity”: “Pochodzenie etniczne”, “African Americans”: “Afroamerykanie”, “Hispanic Americans”: “Amerykanie pochodzenia latynoskiego”, “Native Americans”: “Rdzenni Amerykanie”, “Asian Americans”: “Amerykanie pochodzenia azjatyckiego”, “Clinical Manifestations”: “Objawy kliniczne”, “polyuria”: “Wielomocz”, “polydipsia”: “Nadmierne pragnienie”, “polyphagia”: “Nadmierny apetyt”, “weight loss”: “Utrata masy ciała”, “fatigue”: “Zmęczenie”, “blurred vision”: “Zamglone widzenie”, “microvascular complications”: “Powikłania mikronaczyniowe”, “diabetic retinopathy”: “Retinopatia cukrzycowa”, “diabetic nephropathy”: “Nefropatia cukrzycowa”, “diabetic neuropathy”: “Neuropatia cukrzycowa”, “macrovascular complications”: “Powikłania makronaczyniowe”, “cardiovascular disease”: “Choroba sercowo-naczyniowa”, “poor wound healing”: “Słabe gojenie ran”, “diagnostic criteria”: “Kryteria diagnostyczne”, “American Diabetes Association”: “Amerykańskie Towarzystwo Diabetologiczne”, “fasting plasma glucose (FPG)”: “Glukoza w osoczu na czczo”, “oral glucose tolerance test (OGTT)”: “Doustny test tolerancji glukozy”, “A1C test”: “Test hemoglobiny glikowanej”, “random plasma glucose”: “Przypadkowy poziom glukozy w osoczu”, “type 1 diabetes”: “Cukrzyca typu 1”, “insulin therapy”: “Terapia insulinowa”, “continuous glucose monitoring (CGM)”: “Ciągłe monitorowanie glukozy”, “lifestyle modifications”: “Zmiany stylu życia”, “diet and exercise”: “Dieta i ćwiczenia”, “oral hypoglycemic agents”: “Doustne leki hipoglikemizujące”, “metformin”: “Metformina”, “sulfonylureas”: “Pochodne sulfonylomocznika”, “GLP-1 receptor agonists”: “Agoniści receptora GLP-1”, “SGLT2 inhibitors”: “Inhibitory SGLT2”, “complications”: “Powikłania”, “hypoglycemia”: “Hipoglikemia”, “diabetic ketoacidosis (DKA)”: “Kwasica ketonowa cukrzycowa”, “Type 2 diabetes”: “Cukrzyca typu 2”, “prolonged cortisol exposure”: “Przedłużona ekspozycja na kortyzol”, “adrenal tumors”: “Guzy nadnerczy”, “pituitary adenomas”: “Gruczolaki przysadki”, “Cushing’s disease”: “Choroba Cushinga”, “ectopic ACTH”: “Ektopowe wydzielanie ACTH”, “corticosteroid medications”: “Leki kortykosteroidowe”, “iatrogenic”: “Jatrogenny”, “muscle weakness”: “Osłabienie mięśni”, “psychological changes”: “Zmiany psychiczne”, “24-hour urinary free cortisol”: “Wolny kortyzol w moczu 24-godzinnym”, “dexamethasone suppression test”: “Test hamowania deksametazonem”, “surgical intervention”: “Interwencja chirurgiczna”, “medical therapy”: “Leczenie farmakologiczne”, “ketoconazole”: “Ketokonazol”, “mitotane”: “Mitotan”, “mifepristone”: “Mifepriston”, “Addison’s Disease”: “Choroba Addisona”, “primary adrenal insufficiency”: “Pierwotna niewydolność nadnerczy”, “cortisol deficiency”: “Niedobór kortyzolu”, “aldosterone deficiency”: “Niedobór aldosteronu”, “autoimmune adrenalitis”: “Autoimmunologiczne zapalenie nadnerczy”, “congenital adrenal hyperplasia”: “Wrodzony przerost nadnerczy”, “glucocorticoids”: “Glikokortykosteroidy”, “fludrocortisone”: “Fludrokortyzon”, “adrenal crisis”: “Przełom nadnerczowy”, “ACTH stimulation test”: “Test stymulacji ACTH”, “hyperpigmentation”: “Hiperpigmentacja”, “orthostatic hypotension”: “Hipotonia ortostatyczna”, “salt craving”: “Łaknienie soli”, “morbidity”: “chorobowość”, “mortality”: “śmiertelność”, “pancreas”: “trzustka”, “satiety”: “sytość”, “Adrenal Hemorrhage”: “Krwotok nadnerczowy”, “tuberculosis”: “gruźlica”, “adrenal glands”: “nadnercza”, “metastatic cancer”: “rak z przerzutami”, “sarcoidosis”: “sarkoidoza”, “adrenal insufficiency”: “niewydolność nadnerczy”, “Hypotension”: “niedociśnienie”, “Nausea and Vomiting”: “nudności i wymioty”, “Serum Cortisol”: “kortyzol w surowicy”, “Hormone Replacement Therapy”: “terapia zastępcza hormonami”, “Mineralocorticoids”: “mineralokortykosteroidy”, “intravenous”: “dożylny”, “adrenocorticotropic hormone”: “hormon adrenokortykotropowy”, “cortisol”: “kortyzol”, “aldosterone”: “aldosteron”, “Osteoporosis”: “osteoporoza”, “Diabetes”: “cukrzyca”, “Pituitary Gland”: “przysadka mózgowa”, “Adrenal Glands”: “nadnercza”, “Late-Night Salivary Cortisol”: “wieczorny kortyzol w ślinie”, “Low-Dose”: “niska dawka” }; // Normalize keys in the dictionary const normalizedWordsToTooltip = {}; for (const [key, value] of Object.entries(wordsToTooltip)) { const cleanedKey = key.replace(/(.*?)/g, ”).trim(); // Remove anything in parentheses normalizedWordsToTooltip[cleanedKey.toLowerCase()] = value; } function processNode(node) { if (node.nodeType === Node.TEXT_NODE && node.nodeValue.trim()) { let content = node.nodeValue; // Regex to match only the main words (ignores parentheses) const regex = new RegExp( `\b(${Object.keys(normalizedWordsToTooltip).join(‘|’)})\b`, ‘gi’ ); if (regex.test(content)) { const wrapper = document.createElement(‘span’); wrapper.innerHTML = content.replace(regex, (match) => { const tooltip = normalizedWordsToTooltip[match.toLowerCase().trim()]; return `${match}`; }); node.replaceWith(wrapper); } } else if (node.nodeType === Node.ELEMENT_NODE) { Array.from(node.childNodes).forEach(processNode); } } document.querySelectorAll(‘body *:not(script):not(style)’).forEach((element) => { Array.from(element.childNodes).forEach(processNode); }); });Podświetlanie tekstu z notatkami body { margin: 0; padding: 0; font-family: Arial, sans-serif; } .highlight { background-color: #cce7ff; /* Highlight color without notes */ position: relative; display: inline; } .highlight.with-note { background-color: #ffeb3b; /* Highlight color with notes */ } .note-box { position: absolute; background-color: #f9f9f9; color: #333; font-size: 14px; line-height: 1.6; padding: 10px 15px; border: 1px solid #ddd; border-radius: 5px; box-shadow: 0 2px 5px rgba(0, 0, 0, 0.2); max-width: 250px; z-index: 1000; white-space: normal; text-align: left; display: none; /* Hidden by default */ } .note-controls { position: absolute; top: -30px; right: -30px; display: flex; gap: 10px; z-index: 10; opacity: 0; pointer-events: none; transition: opacity 0.3s; } .note-controls.visible { opacity: 1; pointer-events: all; } .note-controls span { cursor: pointer; background-color: gray; color: white; padding: 5px 10px; border-radius: 5px; font-size: 16px; font-weight: bold; } .note-controls span:hover { background-color: darkgray; } document.addEventListener(“DOMContentLoaded”, () => { /** * Checks if an element is a header. */ const isHeaderElement = (node) => { while (node) { if (node.nodeType === 1 && node.tagName.match(/^H[1-5]$/)) { return true; } node = node.parentNode; } return false; }; /** * Checks if an element is inside a table cell. */ const isInsideTable = (node) => { while (node) { if (node.tagName === “TD” || node.tagName === “TH”) { return node; } node = node.parentNode; } return null; }; /** * Checks if an element belongs to the same list item. */ const isWithinSameListItem = (selection) => { if (selection.rangeCount === 0) return false; const range = selection.getRangeAt(0); const startContainer = range.startContainer; const endContainer = range.endContainer; const getClosestListItem = (node) => { while (node) { if (node.nodeType === 1 && node.tagName === “LI”) { return node; } node = node.parentNode; } return null; }; const startListItem = getClosestListItem(startContainer); const endListItem = getClosestListItem(endContainer); // Ensure selection is within the same list item return startListItem === endListItem; }; /** * Validates the selection. * Ensures the selection is within a single header, table cell, or list item. */ const isSelectionValid = (selection) => { if (selection.rangeCount === 0) return false; const range = selection.getRangeAt(0); const startContainer = range.startContainer; const endContainer = range.endContainer; const startInHeader = isHeaderElement(startContainer); const endInHeader = isHeaderElement(endContainer); // Block selection spanning headers if (startInHeader !== endInHeader) { return false; } const startCell = isInsideTable(startContainer); const endCell = isInsideTable(endContainer); // Block selection spanning table cells if (startCell && endCell && startCell !== endCell) { return false; } // Block selection spanning multiple list items if (!isWithinSameListItem(selection)) { return false; } return true; }; /** * Highlights the selected text. */ const wrapTextWithHighlight = (range) => { const fragment = range.extractContents(); const highlight = document.createElement(“span”); highlight.className = “highlight”; highlight.appendChild(fragment); range.insertNode(highlight); const noteControls = document.createElement(“div”); noteControls.className = “note-controls visible”; const editNote = document.createElement(“span”); editNote.textContent = “✎”; editNote.title = “Edit note”; noteControls.appendChild(editNote); const removeHighlight = document.createElement(“span”); removeHighlight.textContent = “x”; removeHighlight.title = “Remove highlight”; noteControls.appendChild(removeHighlight); highlight.style.position = “relative”; highlight.appendChild(noteControls); let noteBox = null; const updateNotePosition = () => { const rect = highlight.getBoundingClientRect(); if (noteBox) { noteBox.style.top = `${rect.height}px`; noteBox.style.left = `${rect.width / 2}px`; } }; const hideControlsAndNoteAfterDelay = () => { setTimeout(() => { noteControls.classList.remove(“visible”); if (noteBox) noteBox.style.display = “none”; }, 3000); }; // Show controls for 3 seconds after highlighting hideControlsAndNoteAfterDelay(); highlight.addEventListener(“click”, () => { noteControls.classList.add(“visible”); if (noteBox) noteBox.style.display = “block”; hideControlsAndNoteAfterDelay(); }); editNote.addEventListener(“click”, () => { const noteText = prompt(“Add or edit a note:”, noteBox?.textContent || “”); if (noteText) { if (!noteBox) { noteBox = document.createElement(“div”); noteBox.className = “note-box”; highlight.appendChild(noteBox); } noteBox.textContent = noteText; noteBox.style.display = “block”; highlight.classList.add(“with-note”); updateNotePosition(); hideControlsAndNoteAfterDelay(); } }); removeHighlight.addEventListener(“click”, () => { const parent = highlight.parentNode; while (highlight.firstChild) { parent.insertBefore(highlight.firstChild, highlight); } parent.removeChild(highlight); if (noteBox) noteBox.remove(); }); }; /** * Handles the mouseup event to validate and apply highlighting. */ document.body.addEventListener(“mouseup”, () => { const selection = window.getSelection(); if (selection.rangeCount > 0 && selection.toString().trim()) { if (!isSelectionValid(selection)) { alert(“Zaznaczenie musi być w obrębie jednego akapitu, komórki tabeli lub punktu listy!”); selection.removeAllRanges(); return; } const range = selection.getRangeAt(0); wrapTextWithHighlight(range); selection.removeAllRanges(); } }); });
Szacowany czas lekcji: 39 minut
.lesson-duration-container { background-color: #f0f4f8; /* Szarawe tło dopasowane do reszty strony */ padding: 8px 15px; /* Wewnętrzny odstęp */ border-radius: 8px; /* Zaokrąglone rogi */ font-family: ‘Roboto’, Arial, sans-serif; /* Czcionka Roboto, jeśli dostępna */ font-size: 16px; /* Rozmiar tekstu */ color: #6c757d; /* Ciemny szary kolor tekstu */ display: inline-block; /* Wyświetlanie jako element blokowy */ margin-bottom: 20px; /* Odstęp na dole */ border: none; /* Bez obramowania */ } .lesson-duration-label { font-weight: 700; /* Pogrubienie dla etykiety */ color: #6c757d; /* Ciemny szary kolor dla etykiety */ margin-right: 5px; /* Odstęp od wartości */ } .lesson-duration-value { color: #6c757d; /* Ciemny szary kolor dla wartości */ font-weight: 700; /* Pogrubienie dla wartości */ }

Diabetes Mellitus

Diabetes Mellitus is a chronic metabolic disorder characterized by elevated blood glucose levels (hyperglycemia) due to defects in insulin secretion, insulin action, or both. It is one of the most prevalent endocrine disorders worldwide, with significant implications for morbidity and mortality. Diabetes can lead to long-term complications affecting multiple organ systems, including the eyes, kidneys, nerves, and cardiovascular system.

Types of Diabetes Mellitus

TypeDescriptionEtiologyPathophysiology
Type 1 Diabetes (T1D)An autoimmune condition where the immune system attacks and destroys the insulin-producing beta cells in the pancreas. It typically presents in childhood or early adulthood but can occur at any age.The exact cause is unknown, but genetic predisposition and environmental factors (such as viral infections) may play a role.Absolute insulin deficiency leads to high blood glucose levels and requires lifelong insulin therapy for management.
Type 2 Diabetes (T2D)A more common form of diabetes that usually develops in adults, characterized by insulin resistance and relative insulin deficiency. It can occur at any age, especially in individuals with obesity.A combination of genetic factors, sedentary lifestyle, obesity, and poor dietary habits contribute to the development of T2D.The body becomes resistant to the effects of insulin, leading to increased blood glucose levels. Over time, the pancreas may fail to produce enough insulin to overcome this resistance.
Gestational Diabetes Mellitus (GDM)A form of diabetes that occurs during pregnancy and typically resolves after childbirth. However, it increases the risk of developing T2D later in life.Hormonal changes during pregnancy may cause insulin resistance, especially in women with risk factors such as obesity or a family history of diabetes.Insulin resistance during pregnancy leads to elevated blood glucose levels, which can harm both the mother and fetus if not managed properly.
Other Specific TypesThis includes monogenic forms of diabetes, secondary diabetes due to other conditions (e.g., Cushing’s syndrome, pancreatitis), and diabetes related to medication use.Varies by type; may include genetic mutations, hormonal imbalances, or other health conditions.The mechanism varies by specific type; may involve insulin deficiency, resistance, or hormonal alterations.

Risk Factors

Type 1 Diabetes:

  • Family History: Increased risk if a parent or sibling has Type 1 diabetes.
  • Genetics: Certain genetic markers are associated with a higher likelihood of developing the condition.
  • Geography: Higher prevalence in populations further from the equator.
  • Age: Typically diagnosed in two peaks: ages 4-7 and 10-14.

Type 2 Diabetes:

  • Obesity: Particularly central obesity (excess abdominal fat).
  • Sedentary Lifestyle: Lack of physical activity increases risk.
  • Family History: Genetic predisposition plays a significant role.
  • Age: Increased risk with advancing age, especially over 45 years.
  • Ethnicity: Higher prevalence in certain populations, including African Americans, Hispanic Americans, Native Americans, and Asian Americans.

Clinical Manifestations

Classic Symptoms:

  • Polyuria: Increased urination due to osmotic diuresis from high blood glucose levels.
  • Polydipsia: Increased thirst as a result of dehydration from excessive urination.
  • Polyphagia: Increased hunger due to the inability of glucose to enter cells for energy.
  • Weight Loss: Particularly in T1D, despite increased appetite, due to muscle and fat breakdown for energy.
  • Fatigue: General tiredness due to lack of energy utilization.
  • Blurred Vision: Due to lens swelling from fluid changes associated with high glucose levels.

Long-Term Complications:

  • Microvascular Complications:
    • Diabetic Retinopathy: Damage to the retina, potentially leading to blindness.
    • Diabetic Nephropathy: Progressive kidney disease that can result in kidney failure.
    • Diabetic Neuropathy: Nerve damage, which can lead to pain, numbness, and gastrointestinal issues.
  • Macrovascular Complications:
    • Cardiovascular Disease: Increased risk of coronary artery disease, stroke, and peripheral artery disease.
    • Poor Wound Healing: Increased susceptibility to infections and slow healing of cuts and sores.

Diagnostic Approach

Diagnostic Criteria (according to the American Diabetes Association):

  • Fasting Plasma Glucose (FPG): ≥126 mg/dL (7.0 mmol/L) after fasting for at least 8 hours.
  • 2-Hour Plasma Glucose during an Oral Glucose Tolerance Test (OGTT): ≥200 mg/dL (11.1 mmol/L) after a glucose load of 75 grams.
  • A1C Test: ≥6.5% (48 mmol/mol).
  • Random Plasma Glucose: ≥200 mg/dL (11.1 mmol/L) in a patient with classic symptoms of hyperglycemia or hyperglycemic crisis.

Treatment

Type 1 Diabetes:

  • Insulin Therapy: Required for all patients, administered via injections or an insulin pump. The regimen includes basal insulin (long-acting) and bolus insulin (rapid-acting) to cover meals.
  • Continuous Glucose Monitoring (CGM): Helps in managing glucose levels and adjusting insulin doses accordingly.

Type 2 Diabetes:

  • Lifestyle Modifications: Diet and exercise are fundamental in managing blood glucose levels. A balanced diet rich in whole grains, fruits, vegetables, and lean proteins is recommended.
  • Oral Hypoglycemic Agents: Various classes of medications may be used, including:
    • Metformin: First-line treatment that improves insulin sensitivity and reduces hepatic glucose production.
    • Sulfonylureas: Stimulate insulin secretion from the pancreas.
    • GLP-1 Receptor Agonists: Enhance insulin secretion, slow gastric emptying, and promote satiety.
    • SGLT2 Inhibitors: Reduce glucose reabsorption in the kidneys, promoting excretion.
  • Insulin Therapy: May be required for those who cannot achieve target glucose levels with oral medications.

Gestational Diabetes:

  • Dietary Management: Tailored meal plans to control blood sugar levels.
  • Insulin Therapy: May be necessary if blood glucose levels cannot be controlled through diet alone.

Complications

Short-Term Complications:

  • Hypoglycemia: Low blood sugar levels that can cause confusion, irritability, sweating, and fainting. Severe hypoglycemia can lead to seizures or coma.
  • Diabetic Ketoacidosis (DKA): A life-threatening condition in T1D characterized by high levels of ketones due to insufficient insulin, leading to metabolic acidosis.

Long-Term Complications:

  • Microvascular and Macrovascular Issues: As previously discussed, complications can significantly impact the quality of life and lead to increased healthcare costs.

Prognosis

  • Type 1 Diabetes: With proper management, individuals can lead healthy lives, but they remain at risk for complications over time. Advances in insulin therapy and continuous glucose monitoring have improved long-term outcomes significantly.
  • Type 2 Diabetes: Early diagnosis and management can lead to a favorable prognosis. Lifestyle interventions can result in remission in some cases, particularly if implemented early. However, patients are at risk for cardiovascular disease and other complications. Approximately 70% of individuals with T2D will develop some form of complication, underscoring the importance of ongoing monitoring and lifestyle management.

Cushing’s Syndrome

Cushing’s Syndrome is a disorder caused by prolonged exposure to high levels of cortisol, a hormone produced by the adrenal glands. It can result from endogenous overproduction of cortisol due to adrenal tumors, pituitary adenomas (Cushing’s disease), or ectopic ACTH (adrenocorticotropic hormone) production. Alternatively, Cushing’s Syndrome can be iatrogenic, resulting from the prolonged use of corticosteroid medications.

Etiology and Risk Factors

  • Pituitary Adenomas: The most common cause of Cushing’s Syndrome is a pituitary tumor that secretes excess ACTH, stimulating cortisol production by the adrenal glands.
  • Adrenal Tumors: Adrenal adenomas or carcinomas can directly produce excess cortisol.
  • Ectopic ACTH Syndrome: Some tumors outside the pituitary gland, such as small cell lung cancer, can produce ACTH, leading to increased cortisol production.
  • Iatrogenic Causes: Long-term use of corticosteroid medications for other conditions (e.g., autoimmune diseases, asthma) can induce Cushing’s-like symptoms.

Pathophysiology

Cortisol plays a critical role in regulating metabolism, immune response, and stress responses. Excessive cortisol leads to a range of metabolic changes, including increased gluconeogenesis, fat deposition, protein catabolism, and immune suppression. These changes contribute to the characteristic features of Cushing’s Syndrome and can lead to serious health complications.

Clinical Manifestations

Cushing’s Syndrome is characterized by a variety of symptoms and signs, which can develop gradually:

  • Weight Gain: Central obesity with a rounded face (moon facies) and a fat pad on the back of the neck (buffalo hump).
  • Skin Changes: Thin, fragile skin that bruises easily, purple striae (stretch marks), and acne.
  • Hypertension: Elevated blood pressure due to increased cortisol levels.
  • Glucose Intolerance: Increased blood sugar levels, which can lead to diabetes mellitus.
  • Muscle Weakness: Proximal muscle weakness, particularly in the shoulders and hips.
  • Psychological Changes: Mood swings, depression, and cognitive difficulties.

Diagnostic Approach

  • Clinical Evaluation: A thorough history and physical examination to assess symptoms and risk factors.
  • Laboratory Tests:
    • 24-Hour Urinary Free Cortisol: Elevated levels suggest hypercortisolism.
    • Late-Night Salivary Cortisol: Elevated levels can indicate Cushing’s Syndrome.
    • Low-Dose Dexamethasone Suppression Test: Failure to suppress cortisol production indicates Cushing’s Syndrome.
  • Imaging Studies:
    • CT or MRI of the Adrenal Glands: To identify adrenal tumors.
    • MRI of the Pituitary Gland: To detect pituitary adenomas.

Treatment

  • Surgical Intervention: The primary treatment for Cushing’s Syndrome caused by a pituitary adenoma (Cushing’s disease) or adrenal tumor is surgical removal of the tumor.
  • Medical Therapy: Medications such as ketoconazole, mitotane, or mifepristone may be used to control cortisol production in patients who are not surgical candidates or to manage symptoms preoperatively.
  • Radiation Therapy: May be considered for pituitary adenomas when surgery is not an option or if there is residual disease after surgery.

Complications

  • Cardiovascular Disease: Increased risk of hypertension, heart disease, and stroke.
  • Diabetes: Elevated blood sugar levels can lead to new-onset diabetes or worsen existing diabetes.
  • Osteoporosis: Increased bone loss leading to fractures due to long-term exposure to cortisol.
  • Infection: Impaired immune response can increase susceptibility to infections.

Prognosis

  • Variable Outcomes: The prognosis for Cushing’s Syndrome largely depends on the underlying cause and treatment response. After successful surgical treatment, approximately 70-80% of patients experience significant symptom improvement. However, untreated Cushing’s Syndrome has a mortality rate of up to 50% due to complications such as cardiovascular disease and infections. 

Addison’s Disease

Addison’s Disease, also known as primary adrenal insufficiency, is a rare but serious endocrine disorder characterized by insufficient production of cortisol and often aldosterone by the adrenal glands. This condition results from damage to the adrenal cortex, leading to a deficiency in these vital hormones, which play crucial roles in metabolism, immune response, and blood pressure regulation.

Etiology and Risk Factors

  • Autoimmune Destruction: The most common cause of Addison’s Disease is autoimmune adrenalitis, where the body’s immune system mistakenly attacks the adrenal glands.
  • Infections: Certain infections, such as tuberculosis or HIV, can damage the adrenal glands.
  • Genetic Factors: Some individuals may have a hereditary predisposition to autoimmune conditions that can affect the adrenal glands.
  • Adrenal Hemorrhage: Severe physical stress, such as trauma or sepsis, can lead to bleeding in the adrenal glands, causing acute adrenal insufficiency.
  • Other Causes: Conditions such as metastatic cancer, sarcoidosis, or congenital adrenal hyperplasia may also lead to adrenal insufficiency.

Pathophysiology

In Addison’s Disease, the adrenal glands fail to produce adequate levels of cortisol and aldosterone. Cortisol deficiency affects various bodily functions, leading to decreased glucose metabolism, increased fatigue, and a reduced ability to respond to stress. Aldosterone deficiency results in impaired sodium retention, leading to hyponatremia (low sodium levels), hyperkalemia (high potassium levels), and volume depletion.

Clinical Manifestations

  • Fatigue and Weakness: Persistent fatigue, muscle weakness, and lack of energy.
  • Weight Loss and Decreased Appetite: Unintentional weight loss and reduced desire to eat.
  • Hyperpigmentation: Darkening of the skin, particularly in areas exposed to the sun or where friction occurs, due to elevated levels of adrenocorticotropic hormone (ACTH).
  • Hypotension: Low blood pressure, particularly upon standing (orthostatic hypotension), can lead to dizziness or fainting.
  • Nausea and Vomiting: Gastrointestinal symptoms may occur, including abdominal pain.
  • Salt Craving: Increased desire for salty foods due to sodium loss.

Diagnostic Approach

  • Clinical Evaluation: A thorough history and physical examination to assess symptoms and risk factors.
  • Laboratory Tests:
    • Serum Cortisol: Low levels of cortisol, particularly in the morning.
    • ACTH Levels: Elevated ACTH levels indicate primary adrenal insufficiency.
    • Electrolyte Levels: Hyponatremia and hyperkalemia are common findings.
  • ACTH Stimulation Test: A test to evaluate adrenal function by measuring cortisol response to an injection of synthetic ACTH.
  • Imaging Studies: CT or MRI may be used to assess adrenal gland structure and rule out other conditions.

Treatment

  • Hormone Replacement Therapy: The primary treatment for Addison’s Disease is lifelong replacement of deficient hormones:
    • Glucocorticoids: Such as hydrocortisone or prednisone to replace cortisol.
    • Mineralocorticoids: Such as fludrocortisone to replace aldosterone and help maintain sodium balance.
  • Stress Management: Patients should be educated about adjusting medication doses during periods of stress, illness, or surgery to prevent adrenal crisis.

Complications

  • Adrenal Crisis: A life-threatening condition that can occur due to inadequate hormone replacement, characterized by severe hypotension, hypoglycemia, and shock. It requires immediate medical intervention with intravenous glucocorticoids and fluids.
  • Electrolyte Imbalances: Prolonged untreated Addison’s can lead to severe imbalances, potentially resulting in cardiac complications.

Prognosis

  • Generally Good with Treatment: With appropriate lifelong hormone replacement therapy, individuals with Addison’s disease can lead normal, healthy lives. Early diagnosis and treatment are crucial to prevent adrenal crises, which can be life-threatening. Most patients can manage their symptoms effectively, but they require ongoing monitoring and adjustment of medications.